Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC IL-17A inhibitor 1 | 2452464-73-0 | MFCD34474218 | >98.0% | C24H27F5N8O4 | 10MG
Supplier: Medchemexpress LLC HY13920610MG
LY3509754 is an orally active small-molecule inhibitor of interleukin-17A (IL-17A) developed by Eli Lilly. It exhibits low-nanomolar potency in biochemical and cell-based assays, has been evaluated in early-phase clinical studies, and is supplied for research use with documented purity and supporting analytical data.
- Potent IL-17A inhibition with low-nanomolar IC50 values.
- Demonstrated cellular activity in HT-29 and NHDF assays.
- Supplied for research use with documented purity greater than 98.0%.
- Orally active small-molecule chemical class appropriate for pharmacology studies.
- Supported by preclinical and Phase 1 clinical data for translational research.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?